| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |